Cucurbitacin E
Cucurbitacin E is a bioactive compound found in the Cucurbitaceae family of plants, which includes species such as cucumbers, melons, and squashes. It is one of the many cucurbitacins, a class of triterpenoids known for their bitter taste and potential health benefits.
Chemical Structure and Properties
Cucurbitacin E, also known as alpha-elaterin, has a complex molecular structure characterized by a tetracyclic triterpenoid skeleton. It is a highly oxygenated compound, with several hydroxyl and carbonyl groups. This compound is known for its bitter taste, which is a common characteristic of cucurbitacins.
Biological Activity
Cucurbitacin E has been studied for its potential pharmacological effects. It has been found to exhibit anti-inflammatory, anti-cancer, and anti-diabetic activities in various in vitro and in vivo studies. The anti-cancer activity of Cucurbitacin E is believed to be due to its ability to inhibit the STAT3 signaling pathway, which is often overactive in cancer cells.
Sources
Cucurbitacin E is found in various plants in the Cucurbitaceae family. It is most commonly found in the roots, stems, and leaves of these plants. The concentration of Cucurbitacin E can vary greatly depending on the species of plant and its growing conditions.
Potential Health Benefits
While more research is needed, some studies suggest that Cucurbitacin E may have potential health benefits. Its anti-inflammatory properties could potentially be used to treat conditions such as rheumatoid arthritis and asthma. Its anti-cancer activity could potentially be used to develop new treatments for various types of cancer.
Safety and Toxicity
Cucurbitacins, including Cucurbitacin E, are known to be toxic in high doses. They can cause gastrointestinal upset and, in severe cases, can lead to liver damage or death. Therefore, while Cucurbitacin E has potential health benefits, it must be used with caution.
See Also
| Cucurbitaceae Family | ||||||
|---|---|---|---|---|---|---|
This Cucurbitaceae related article is a stub.
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD